David T. MacLaughlin

Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells

Richard L. Cate, Robert J. Mattaliano, Catherine Hession et al. · Cell · 1986 · 1K citations

Müllerian Inhibiting Substance, Genetics, Human Genes +9

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

Paul P. Szotek, Rafael Pieretti‐Vanmarcke, Peter T. Masiakos et al. · Proceedings of the National Academy of Sciences · 2006 · 756 citations · Full text

Oncogenic Agent, Medicine, Stem Cells +14

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

David B. Seifer, David T. MacLaughlin, Benjamin P. Christian et al. · Fertility and Sterility · 2002 · 491 citations

Infertility, Hormonal Contraceptive, Fertility +11

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

Mary Lee, Patricia K. Donahoe, Tomonobu Hasegawa et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 410 citations · Full text

Fertility, Reproductive Health, Pathology +20

Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes

Sibel Kantarci, Lihadh Al‐Gazali, R. Sean Hill et al. · Nature Genetics · 2007 · 315 citations · Full text

Glomerulonephritis, Urology, Mendelian Disorder +10